Is SGEN or VYM a better dividend investment in 2026?

SGEN currently yields 0.87% with a 5% 5-year dividend growth rate. VYM yields 2.41% with 7.8% growth. The better choice depends on your goal: VYM offers higher current income.

What is the dividend yield difference between SGEN and VYM?

SGEN has a forward dividend yield of 0.87% ($2.00/share annually). VYM yields 2.41% ($3.51/share annually). The yield gap is 1.54 percentage points.

Home › Compare › SGEN vs VYM

SGEN vs VYM: Dividend Comparison 2026

SGEN yields 0.87% · VYM yields 2.41%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VYM wins by $6.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SGEN

● Live price

0.87%

Share price

$228.74

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.9K

Annual income

$92.54

Full SGEN calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.41%

Share price

$145.48

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$278.55

Full VYM calculator →

Portfolio growth — SGEN vs VYM

📍 VYM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SGEN	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SGEN + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SGEN pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SGEN

Annual income on $10K today (after 15% tax)

$74.32/yr

After 10yr DRIP, annual income (after tax)

$78.66/yr

VYM

Annual income on $10K today (after 15% tax)

$205.23/yr

After 10yr DRIP, annual income (after tax)

$236.77/yr

At 15% tax rate, VYM beats the other by $158.11/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SGEN + VYM for your $10,000?

SGEN: 50%VYM: 50%

100% VYM50/50100% SGEN

Portfolio after 10yr

$24.4K

Annual income

$185.54/yr

Blended yield

0.76%

📊

Analyst Conviction Gap

Where Wall Street is split right now

SGEN

No analyst data

Price Target

$171.82

-24.9% upside vs current

Range: $120.00 — $222.00

Altman Z

23.3

Piotroski

2/9

VYM

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SGEN buys

VYM buys

No recent congressional trades found for SGEN or VYM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSGENVYM

Forward yield	0.87%	2.41% ✓
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$20.9K	$27.8K ✓
Annual income after 10y	$92.54	$278.55 ✓
Total dividends collected	$902.00 ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SGEN vs VYM ($10,000, DRIP)

Year	SGEN Portfolio	SGEN Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$10,787	$87.44	$11,151	$241.44	$364.00 → VYM
2	$11,631	$88.15	$12,413	$246.79	$782.00 → VYM
3	$12,534	$88.82	$13,794	$251.79	$1.3K → VYM
4	$13,500	$89.46	$15,306	$256.47	$1.8K → VYM
5	$14,536	$90.05	$16,960	$260.84	$2.4K → VYM
6	$15,644	$90.62	$18,768	$264.92	$3.1K → VYM
7	$16,830	$91.14	$20,745	$268.71	$3.9K → VYM
8	$18,100	$91.64	$22,905	$272.24	$4.8K → VYM
9	$19,459	$92.11	$25,265	$275.51	$5.8K → VYM
10	$20,913	$92.54	$27,842	$278.55	$6.9K → VYM

SGEN vs VYM: Complete Analysis 2026

SGEN — Stock

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

Full SGEN Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this SGEN vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SGEN vs SCHD SGEN vs JEPI SGEN vs O SGEN vs KO SGEN vs MAIN SGEN vs VIG SGEN vs DGRO SGEN vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.